A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer.

Breast Cancer · 2022 · PMC9021102 · PMID 35061208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Though the difference did not reach statistical significance, the low-risk group showed a better OS in the GSE58812 cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.